News

Jesper Nordengaard appointed as CEO of Dechra

May 16, 2024 -Dechra Pharmaceuticals Limited today announces the appointment of Jesper Nordengaard as its CEO and retirement of Ian Page effective June 10, 2024.

Dechra scoop three awards at the Veterinary Marketing Association awards

Dechra has won a hat trick of awards at the prestigious Veterinary Marketing Association (VMA) Awards 2023 which were held on Friday 17 March at the Royal Lancaster Hotel in London.

Dechra takes on distribution of Ketodolor®

Dechra has taken on the distribution of Ketodolor®, the non-steroidal anti-inflammatory (NSAID) and anti-rheumatic product for cattle, pigs and horses.